CuroGens Europa IVS: Financial statements 2020
CVR: 37602736
Source: annual report 2020, Danish Business Authority
01/01/2020 – 31/12/2020
CuroGens Europa IVS (CVR 37602736) has filed annual accounts for 2020. In 2020, the company reported revenue of DKK 1,824,494 and a net result of DKK 15,632 compared with DKK -57,502 the year before. That is a decrease of 30.1% compared with the year before. The profit margin was 0.9%. Equity in the 2020 report amounted to DKK 44,407. The solvency ratio was 83.4%. The company had 1 employee in the financial year.
- Revenue
- DKK 1,824,494
- Gross Profit
- DKK 122,233
- Profit/Loss
- DKK 15,632
- Equity
- DKK 44,407
- Total Assets
- DKK 53,259
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | 1.8M | 122K | 16K | 44K | 1 |
| 2019 | 2.6M | 97K | -58K | 30K | - |
| 2018 | 2.1M | 5K | 536 | 636 | - |
| 2017 | 2.6M | 257K | 206K | 206K | - |
Official annual report
How creditworthy is CuroGens Europa IVS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
CuroGens Europa IVS has published its annual report for 2019. Revenue came to DKK 2,609,943, and the net result was DKK -57,502.
About CuroGens Europa IVS
CuroGens Europa IVS was a Danish company of the type Iværksætterselskab based in Aarhus C, founded in 2016. The company has been dissolved on 20 December 2021. The company was registered under the industry Konsulentbistand vedrørende informationsteknologi. The company has 1 employee (2020). In 2020, the company reported revenue of DKK 1,824,494 and a net result of DKK 15,632 compared with DKK -57,502 the year before. Equity in the 2020 report amounted to DKK 44,407.
